SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹414 Cr | ₹343 Cr | ₹369 Cr | ₹327 Cr | ₹511 Cr |
What is the latest Long Term Provisions ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹414 Cr |
Mar2023 | ₹343 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹327 Cr |
Mar2020 | ₹511 Cr |
How is Long Term Provisions of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹414 Cr | 20.70 | |
Mar2023 | ₹343 Cr | -7.09 | |
Mar2022 | ₹369 Cr | 12.82 | |
Mar2021 | ₹327 Cr | -35.98 | |
Mar2020 | ₹511 Cr | - |
Compare Long Term Provisions of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹431,346.2 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
MANKIND PHARMA | ₹102,231.0 Cr | -2.1% | -0.6% | 33.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 1.7% |
-4.7% |
48.8% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses